Ticker LaunchIPO · ELAB
PMGC Holdings Inc.
Formerly Elevai Labs Inc.; Reactive Medical Labs Inc.
PMGC Holdings Inc. (ELAB) priced its initial public offering on Nov 22, 2023 at $4.00 per share, raising $6M, and listed on Nasdaq Capital Market. At the IPO price its market capitalization was about $69.3M. Univest was lead-left underwriter. Ortoli Rosenstadt advised the company and Hunter Taubman Fischer & Li advised the underwriters.
At its 2023 IPO, Elevai Labs, Inc. (now PMGC Holdings) was a physician-dispensed skincare company founded in 2020. It researched and produced topical skincare products, including Elevai Exosomes, that complement the medical aesthetics industry, selling mainly business-to-business.
- Status
- IPO
- Ticker
- ELAB
- Exchange
- Nasdaq Capital Market
- Priced
- Nov 22, 2023
- IPO price
- $4.00
- Raised
- $6M
- Market cap at IPO price
- $69.3M
- First filed
- Sep 29, 2023
- Underwriters
- Univest
- Company counsel
- Ortoli Rosenstadt
- Underwriters' counsel
- Hunter Taubman Fischer & Li
- Sector
- Biotech & pharma
- Country / state
- CA
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Sep 29, 2023
- Latest amendment Nov 9, 2023
- Final prospectus (424B4) Nov 22, 2023
- All filings on EDGAR CIK 1840563
Other Biotech & pharma IPOs in 2023
- CARGO Therapeutics, Inc.CRGX · Nov 13, 2023 · $281.2M
- Lexeo Therapeutics, Inc.LXEO · Nov 6, 2023 · $100M
- Abivax S.A.ABVX · Oct 23, 2023 · $235.8M
- Neumora Therapeutics, Inc.NMRA · Sep 18, 2023 · $250.1M
- RayzeBio, Inc.RYZB · Sep 18, 2023 · $311M
- Mira Pharmaceuticals, Inc.MIRA · Aug 4, 2023 · $8.9M